Nasdaq · Healthcare

PRECISION OPTICS CORPORATION, INC. (POCI)

As-reported financials and recent SEC filings for PRECISION OPTICS CORPORATION, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$19.1M

Net income

$-5.8M

Net margin

-30.3%

Diluted EPS

$-0.85

ROE

-47.2%

P/E (TTM)

—

Market cap

—

Debt / equity

0.1×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$19.1M	$19.1M	$21.0M	$15.7M	$10.7M
Gross profit	$3.4M	$5.8M	$7.7M	$4.9M	$3.4M
Operating income	$-5.6M	$-2.7M	$-638,548	$-1.5M	$-905,583
Net income	$-5.8M	$-3.0M	$-144,613	$-928,416	$-102,835
Diluted EPS	$-0.85	$-0.49	$-0.03	$-0.18	$-0.03

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

SCHEDULE 13G/A2026-05-14

10-Q2026-05-13

32026-05-06

32026-04-06

42026-04-02

42026-04-01

42026-04-01

42026-04-01

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on POCI

Search PRECISION OPTICS CORPORATION, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.